Vindon Scientific USA is categorized under Pharmaceutical Machinery Manufacturers in Kennesaw, GA and active since 1967.
Vindon Scientific USA was established in 1967, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pharmaceutical Machinery Manufacturers business, which does work in the B2B market, and is classified as a Pharmaceutical Machinery Manufacturers, under code number by the NAICS.
If you are seeking more information, feel free to contact Megan Kosiba at the company’s branch by writing to 300 Townpark Drive, Building 1, Suite 130, Kennesaw, Kennesaw, Georgia GA 30144 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Vindon Scientific USA |
Contact Person: | Megan Kosiba |
Address: | 300 Townpark Drive, Building 1, Suite 130, Kennesaw, Kennesaw, Georgia 30144 |
Website Address: | vindonscientific.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1967 |
Location Type: | Branch |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Pharmaceutical Machinery Manufacturers |
Share This Business: |
Vindon Scientific USA was started in 1967 to provide professional Pharmaceutical Machinery Manufacturers under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Megan Kosiba for inquiries that concern Vindon Scientific USA by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the branch of Vindon Scientific USA can be found at the coordinates 33.748310089111,-84.391 as well as the street address 300 Townpark Drive, Building 1, Suite 130, Kennesaw in Kennesaw, Georgia 30144.
For its online presence, you may visit Vindon Scientific USA’s website at vindonscientific.com and engage with its social media outlets through on Twitter and on Facebook.